Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
- 1 April 2014
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 63 (16), 1593-1603
- https://doi.org/10.1016/j.jacc.2014.01.014
Abstract
No abstract availableFunding Information
- American Heart Association
- National Institutes of Health
- Gilead, Novartis, and XOMA
- Gilead and Novartis
This publication has 100 references indexed in Scilit:
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]The American Journal of Cardiology, 2013
- Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human studyPublished by BMJ ,2013
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouseProceedings of the National Academy of Sciences of the United States of America, 2011
- Involvement of Phosphoinositide 3-Kinase γ in Angiogenesis and Healing of Experimental Myocardial Infarction in MiceCirculation Research, 2010
- Humanized cobra venom factor decreases myocardial ischemia–reperfusion injuryMolecular Immunology, 2009
- Inflammation in Atherosclerosis From Pathophysiology to PracticeJournal of the American College of Cardiology, 2009
- The role of IL-1 in the pathogenesis of heart diseaseArchivum Immunologiae et Therapiae Experimentalis, 2009
- IL-10 Inhibits Inflammation and Attenuates Left Ventricular Remodeling After Myocardial Infarction via Activation of STAT3 and Suppression of HuRCirculation Research, 2009
- The immune system and cardiac repairPharmacological Research, 2008
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006